Last reviewed · How we verify

NCT07294222

Intervention for Preventing Myopia and Multimorbidity in Children

Not yet recruiting NA Last updated 24 December 2025
What this trial tests

NA trial testing Standard School Health Education in Myopia in 4,000 participants. Not yet recruiting.

Timeline
30 December 2025
Primary endpoint
30 December 2026
30 January 2027

Quick facts

Lead sponsorFangbiao Tao
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment4,000
Start date30 December 2025
Primary completion30 December 2026
Estimated completion30 January 2027

Drugs / interventions tested

Conditions studied

Sponsor

Fangbiao Tao — full company profile →

Who can join

Adults 8 to 11, any sex, with Myopia or Mental Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to develop and evaluate a scalable, hybrid intervention model for the co-prevention of myopia, obesity, and mental health issues among children. By integrating cognitive behavioral therapy principles, the model targets key modifiable lifestyle factors-including dietary nutrition, physical activity, screen time, sleep hygiene, light exposure, and psychological adaptation-through coordinated family-school engagement and online-to-offline delivery. Using a cluster randomized controlled trial design in grades 3-4 primary school students, the research will assess the effectiveness of this multi-component strategy in reducing the incidence and burden of these co-occurring conditions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Fangbiao Tao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07294222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing